当前位置:
X-MOL 学术
›
Org. Lett.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Aspertaichunol A, an Immunomodulatory Polyketide with an Uncommon Scaffold from the Insect-Derived Endophytic Aspergillus taichungensis SMU01
Organic Letters ( IF 4.9 ) Pub Date : 2022-09-25 , DOI: 10.1021/acs.orglett.2c02978 Xia Cheng 1 , Fo-Pei Ma 2 , Yong-Ming Yan 3 , Wen-Li Zhao 4 , Jin Shi 5 , Wei Xiao 1 , En-Guang Bi 4 , Qi Luo 1, 2
Organic Letters ( IF 4.9 ) Pub Date : 2022-09-25 , DOI: 10.1021/acs.orglett.2c02978 Xia Cheng 1 , Fo-Pei Ma 2 , Yong-Ming Yan 3 , Wen-Li Zhao 4 , Jin Shi 5 , Wei Xiao 1 , En-Guang Bi 4 , Qi Luo 1, 2
Affiliation
Aspertaichunol A (1), a polyketide with a novel scaffold, was isolated from the medicinal insect (Periplaneta americana)-derived endophytic Aspergillus taichungensis SMU01. Its structure was assigned on the basis of spectroscopic data and quantum chemical computational methods. Notably, 1 possesses an uncommon tricyclo[6.2.0.02,6]decane motif and an unusual bridgehead double bond (anti-Bredt system). A plausible biosynthetic pathway, involving a key intramolecular [2+2] cycloaddition and a reductive cyclization, is postulated. Finally, the immunomodulatory activity of 1 at 20 nM was evaluated by promoting Th9 cell differentiation from naive CD4+CD62L+ T cells.
中文翻译:
Aspertaichunol A,一种免疫调节聚酮化合物,具有来自昆虫衍生的内生曲霉 taichungensis SMU01 的罕见支架
Aspertaichunol A ( 1 ) 是一种具有新型支架的聚酮化合物,是从药用昆虫 ( Periplaneta americana ) 衍生的内生性Aspergillus taichungensis SMU01 中分离出来的。它的结构是根据光谱数据和量子化学计算方法分配的。值得注意的是,1拥有一个不常见的三环 [6.2.0.0 2,6 ]decane 基序和一个不寻常的桥头双键(反 Bredt 系统)。假设了一个合理的生物合成途径,涉及关键的分子内 [2+2] 环加成和还原环化。最后,通过促进 Th9 细胞从幼稚 CD4 + CD62L分化来评估1在 20 nM 时的免疫调节活性+ T 细胞。
更新日期:2022-09-25
中文翻译:
Aspertaichunol A,一种免疫调节聚酮化合物,具有来自昆虫衍生的内生曲霉 taichungensis SMU01 的罕见支架
Aspertaichunol A ( 1 ) 是一种具有新型支架的聚酮化合物,是从药用昆虫 ( Periplaneta americana ) 衍生的内生性Aspergillus taichungensis SMU01 中分离出来的。它的结构是根据光谱数据和量子化学计算方法分配的。值得注意的是,1拥有一个不常见的三环 [6.2.0.0 2,6 ]decane 基序和一个不寻常的桥头双键(反 Bredt 系统)。假设了一个合理的生物合成途径,涉及关键的分子内 [2+2] 环加成和还原环化。最后,通过促进 Th9 细胞从幼稚 CD4 + CD62L分化来评估1在 20 nM 时的免疫调节活性+ T 细胞。